Early and rapid detection of the causative organism is necessary in tuberculosis. We present here an integrated and dedicated molecular biology system for tuberculosis diagnosis. One hundred and eighty-nine (189) biologic specimens from patients strongly suspected by clinical parameters of tuberculosis were studied by Ziehl–Neelsen staining, cultivation on a solid medium, and by a balanced heminested fluorometric PCR system (Orange G3TB) that preserves worker safety and produces a rather pure material free of potential inhibitors. DNA amplification was carried out in a low cost using a tuberculosis thermocycler-fluorometer. The double stranded DNA produced is fluorometrically detected. The whole reaction is carried out in one single tube which is never opened after adding the processed sample, thus minimizing the risk of cross contamination with amplicons. The assay is able to detect 30 bacilli/ml of sample having a 99.8 % inter-assay coefficient of variation. PCR was positive in 36 (18.9 %) tested samples (33 of them were smear-negative). In our study, it yields a preliminary overall sensitivity of 97.4 %. In addition, its overall specificity is 98.7 %. The total run time of the test is 4 h with two and a half real working hours. All PCR-positive samples also had a positive result by microbiological culture and clinical criteria. The results obtained showed that it could be a very useful tool to increase efficiency in detecting the tuberculosis disease in low bacillus inoculum samples. Furthermore, its low cost and friendly usage make it feasible to be used in regions with poor development.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Ryan, F. (1992). The forgotten plague: how the battle against tuberculosis was won and lost. Boston: Little, Brown and Company. 3.
Dye, C., Watt, C. J., Bleed, D. M., Hosseini, S. M., & Raviglione, M. C. (2005). Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. Journal of the American MedicalAssociation, 293, 2767–2775.
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., et al. (2009). Rapid molecular detection of tuberculosis and rifampin resistance. New England Journal of Medicine, 363(11), 1005–1015.
Kehinde, A. O., Obaseki, F. A., Cadmus, S. I., & Bakare, R. A. (2005). Diagnosis of tuberculosis: urgent need to strengthen laboratory services. Journal of the National Medical Association, 97, 394–396.
Kimerling, M. E. (2000). The Russian equation: an evolving paradigm in tuberculosis control. International Journal of Tuberculosis and Lung Disease, 4, S160–S167.
Marras, T. K. (2003). Tuberculosis among Tibetan refugee claimants in Toronto, 1998–2000. Chest, 124, 915–921.
Moss, A. R. (2000). Tuberculosis in the homeless. A prospective study. American Journal of Respiratory and Critical Care Medicine, 162, 460–464.
Reyes, H., & Coninx, R. (1997). Pitfalls of tuberculosis programmes in prisons. British Medical Journal, 315, 1447–1450.
Elbers, C., Lanjouw, J. O., & Lanjouw, P. (2002). Micro-level estimation of poverty and inequality. Econometric, 71, 355–364.
Evans, T. (Ed.). (2001). Challenging inequities in health: from ethics to action. Oxford: Oxford University Press.
Noordhoek, G. T., Kaan, J. A., Mulder, S., Wilke, H., & Kolk, A. H. (1995). Routine application of the polymerase chain reaction for detection of Mycobacterium tuberculosis in clinical samples. Journal of Clinical Pathology, 48, 810–814.
Watterson, S. A., & Drobniewski, F. A. (2000). Modern laboratory diagnosis of mycobacterial infections. Journal of Clinical Pathology, 53, 727–732.
Urdea, M., Penny, L. A., & Olmsted, S. S. (2006). Requirements for high impact diagnostics in the developing world. Nature, 444(Suppl 1), 73–79.
Raja, S., Ching, J., & Xi, L. (2005). Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing. Clinical Chemistry, 51, 882–890.
Barnes, P. F. (1997). Rapid diagnostic tests for tuberculosis. Progress, but not gold standard. American Journal of Respiratory and Critical Care Medicine, 155, 1497–1498.
Boehme, A., Nabeta, P., Henostroza, G., Raqib, R., Rahim, Z., Gerhardt, M., et al. (2007). Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. Journal of Clinical Microbiology, 45, 1936–1940.
Garberi, J., Labrador, J., Garberi, F., et al. (2011). Diagnosis of Mycobacterium tuberculosis using molecular biology technology. Asian Pacific Journal of Tropical Biomedicine, 2, 89–93.
García-Quintanilla, A., Garcia, L., Tudó, G., Navarro, M., González, J. T., & Jiménez de Anta, M. T. (2000). Single-tube balanced heminested PCR for detecting Mycobacterium tuberculosis in smear-negative samples. Journal of Clinical Microbiology, 38, 1166–1169.
Helb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ken, Ho, et al. (2010). Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use on on-demand, near patient technology. Journal of Clinical Microbiology, 48, 237–239.
Blakemore, R., Story, E., Helb, D., Kop, J. A., Banada, P., Owens, M. R., et al. (2010). Evaluation of the analytical preformance of the Xpert MTB/RIF assay. Journal of Clinical Microbiology, 48, 2495–2501.
Dahle, U. R., Eldholm, V., Winje, B. A., Mannsaker, T., & Heldal, E. (2007). Impact of immigration on the molecular epidemiology of Mycobacterium tuberculosis in a low-incidence country. American Journal of Respiratory and Critical Care Medicine, 176, 930–935.
Mathema, B., Kurepina, N. E., Bifani, P. J., & Kreiswirth, B. N. (2006). Molecular epidemiology of tuberculosis: current insights. Clinical Microbiology Reviews, 19(4), 658–685.
Banada, P. B., Sivasubramani, S. K., Blakemore, R., Boehme, C., Perkins, M., Fennely, K., et al. (2010). Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings. Journal of Clinical Microbiology, 48, 3351–3357.
Bradley, S. P., Reed, S. L., & Catanzaro, A. (1996). Clinical efficacy of the amplified Mycobacterium tuberculosis direct test for the diagnosis of pulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine, 153, 1606.
Schluger, N. W., Kinney, D., Harkin, T. J., & Rom, W. N. (1994). Clinical utility of the polymerase chain reaction in the diagnosis of infections due to Mycobacterium tuberculosis. Chest, 105, 1116.
Dalovisio, J. R., Montenegro-James, S., & Kemmerly, S. A. (1996). Comparison of the amplified Mycobacterium tuberculosis (MTB) direct test, Amplicor MTB PCR, and IS6110-PCR for detection of MTB in respiratory specimens. Clinical Infectious Diseases, 23, 1099.
Rights and permissions
About this article
Cite this article
Garberi, J., Labrador, J., Garberi, F. et al. Rapid and Biosecure Diagnostic Test for Tuberculosis. Cell Biochem Biophys 65, 173–179 (2013). https://doi.org/10.1007/s12013-012-9413-7
- Cerebral spinal fluid
- Pleural liquid
- Molecular diagnosis
- Low cost
- Real-time PCR